Cloning and Expression of Human Membrane-Bound and Soluble Engineered T Cell Receptors for Immunotherapy

We report here the design and construction of several gene vectors for expression in mammalian cells of membrane-bound and soluble human T cell receptors (TR). We designed a vector (TR-ALPHA-IRES-TR-BETA pEF4) that encodes high-level expression of the full-length TR on the surface of T cells. Furthermore, we engineered TR that does not require the presence of endogenous CD3 molecules for surface expression and thus expression is not limited to T cells. We also constructed a vector encoding a single-chain TR (scTR) as a fusion protein of V-ALPHA-V-BETA-C-BETA with CD3Z. Since it is encoded and expressed as a single molecule, this scTR is well suited for gene therapy. Lastly, we successfully used a mammalian expression vector for generation of soluble human TR. The approaches we used here for manipulation of a human tumor-specific TR can be useful for other investigators interested in TR-based immunotherapy.

[1]  M. Weijtens,et al.  Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production , 2000, Gene Therapy.

[2]  Simon C Watkins,et al.  Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1. , 1998, Journal of immunology.

[3]  S. Rosenberg,et al.  High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens , 2003, The Journal of Immunology.

[4]  J W Gratama,et al.  Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR , 2000, Gene Therapy.

[5]  Z. Eshhar,et al.  The T-body approach: potential for cancer immunotherapy , 2004, Springer Seminars in Immunopathology.

[6]  M. Nishimura,et al.  Transfer of TCR Genes into Mature T Cells Is Accompanied by the Maintenance of Parental T Cell Avidity , 2003, The Journal of Immunology.

[7]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[8]  S. Batra,et al.  Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct , 2000, Cancer Immunology, Immunotherapy.

[9]  I. M. Belyakov,et al.  Molecular mechanisms and biological significance of CTL avidity. , 2003, Current HIV research.

[10]  R. Siliciano,et al.  A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C Grégoire,et al.  Covalent assembly of a soluble T cell receptor-peptide-major histocompatibility class I complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Berzofsky,et al.  Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining. , 2001, International immunology.

[13]  R. Klausner,et al.  High-efficiency expression and solubilization of functional T cell antigen receptor heterodimers. , 1992, Science.

[14]  M. Yáñez-Mó,et al.  Cutting Edge: Dynamic Redistribution of Tetraspanin CD81 at the Central Zone of the Immune Synapse in Both T Lymphocytes and APC1 , 2002, The Journal of Immunology.

[15]  G. Linette,et al.  Antimelanoma Activity of CTL Generated from Peripheral Blood Mononuclear Cells After Stimulation with Autologous Dendritic Cells Pulsed with Melanoma gp100 Peptide G209-2M Is Correlated to TCR Avidity , 2002, The Journal of Immunology.

[16]  N. Brouwenstijn,et al.  TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning , 2002, International journal of cancer.

[17]  M. Cascio,et al.  Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution. , 2005, Blood.